DUBLIN, April 6, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Daphne Karydas will join the Company as Senior Vice President of Global Investor Relations and Strategy, effective April 17, 2017. In this role, Ms. Karydas will lead the Company’s engagement with the investment community, and will work […]
Company Receives EPA Honor for 12th Consecutive Year KENILWORTH, N.J. April 6, 2017 –(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that it has received an ENERGY STAR 2017 Partner of the Year – Sustained Excellence Award from the U.S. Environmental Protection Agency (EPA) for its continued improvement of […]
KENILWORTH, N.J. April 5, 2017 –(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that new data from the company’s chronic hepatitis C virus (HCV) clinical development programs as well as real-world studies on ZEPATIER® (elbasvir and grazoprevir) 50mg/100mg tablets will be presented at the upcoming International Liver Congress™ […]
INDIANAPOLIS, April 4, 2017 /PRNewswire/ — Students from Ohio University’s Heritage College of Osteopathic Medicine will soon join Eli Lilly and Company’s (NYSE: LLY) innovative rotation program for aspiring physicians. Launched in early 2014, the program provides students with hands-on experience in a range of pharmaceutical business activities, from drug discovery and development to bioethics and […]
Clinical Program Now Includes Seven Registrational Trials Across Five Tumor Types WILMINGTON, Del. & KENILWORTH, N.J. March 31, 2017 – Incyte Corporation (Nasdaq:INCY) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced additional details of their clinical development program investigating the combination of epacadostat, Incyte’s investigational oral selective IDO1 enzyme […]
The Sir Andrew Witty GSK Scholarships will be funded by GSK and run by the London School of Hygiene & Tropical Medicine 10-year agreement to fund 30 scholars from sub-Saharan Africa on a Master of Science programme London UK – 29 March 2017 – GSK has today announced a new partnership with the London School […]
Significant investment in manufacturing diabetes medicines continues with new $85 million commitment in Indianapolis $5 billion invested in its U.S. operations over the last decade; more favorable tax climate could lead to additional U.S. investments INDIANAPOLIS, March 24, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced plans to invest $850 million in its […]
Recommendation Is for Adult Patients Who Have Failed Autologous Stem Cell Transplant and Brentuximab Vedotin (BV), or Who Are Transplant-Ineligible and Have Failed BV KENILWORTH, N.J. March 24, 2017 –(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the […]
Groundbreaking UK/US initiative will deliver first data within a year London UK – 23 March 2017 – UK Biobank today announced a major research initiative with GSK and the Regeneron Genetics Center (RGC) to generate genetic sequence data from the 500,000 volunteer participants in the UK Biobank resource. The initiative will enable researchers to gain […]
Jointly developed research projects will study diabetes healthcare outcomes for the Latino population SANTA BARBARA, Calif. and INDIANAPOLIS, March 23, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and the William Sansum Diabetes Center have established a research collaboration to improve the lives of Latino people affected by diabetes through enhanced research, education and care. […]